These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 26187754)

  • 21. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
    Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
    JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement?
    Silani V; Calzarossa C; Cova L; Ticozzi N
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):314-24. PubMed ID: 20406179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cells in amyotrophic lateral sclerosis: state of the art.
    Mazzini L; Vercelli A; Ferrero I; Mareschi K; Boido M; Servo S; Oggioni GD; Testa L; Monaco F; Fagioli F
    Expert Opin Biol Ther; 2009 Oct; 9(10):1245-58. PubMed ID: 19663719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motor neuron replacement therapy for amyotrophic lateral sclerosis.
    Liu B; Li M; Zhang L; Chen Z; Lu P
    Neural Regen Res; 2022 Aug; 17(8):1633-1639. PubMed ID: 35017408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell therapy in amyotrophic lateral sclerosis.
    Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
    J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perfluorocarbon Labeling of Human Glial-Restricted Progenitors for
    Richard JP; Hussain U; Gross S; Taga A; Kouser M; Almad A; Campanelli JT; Bulte JWM; Maragakis NJ
    Stem Cells Transl Med; 2019 Apr; 8(4):355-365. PubMed ID: 30618148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction for Stem Cell-Based Therapy for Neurodegenerative Diseases.
    Han F; Lu P
    Adv Exp Med Biol; 2020; 1266():1-8. PubMed ID: 33105491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
    Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
    Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
    Goyal NA; Mozaffar T
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell transplantation for spinal cord neurodegeneration.
    Lepore AC; Maragakis NJ
    Methods Mol Biol; 2011; 793():479-93. PubMed ID: 21913120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis.
    Ciervo Y; Ning K; Jun X; Shaw PJ; Mead RJ
    Mol Neurodegener; 2017 Nov; 12(1):85. PubMed ID: 29132389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Senolytics: A Novel Strategy for Neuroprotection in ALS?
    Maximova A; Werry EL; Kassiou M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
    Bohl D; Pochet R; Mitrecic D; Nicaise C
    Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.
    Giacomelli E; Vahsen BF; Calder EL; Xu Y; Scaber J; Gray E; Dafinca R; Talbot K; Studer L
    Cell Stem Cell; 2022 Jan; 29(1):11-35. PubMed ID: 34995492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stem cells therapy in amyotrophic lateral sclerosis treatment. A critical view].
    Soler B; Fadic R; von Bernhardi R
    Rev Neurol; 2011 Apr; 52(7):426-34. PubMed ID: 21425112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-modifying therapies in amyotrophic lateral sclerosis.
    Chiò A; Mazzini L; Mora G
    Neuropharmacology; 2020 May; 167():107986. PubMed ID: 32062193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis.
    Popescu IR; Nicaise C; Liu S; Bisch G; Knippenberg S; Daubie V; Bohl D; Pochet R
    Stem Cells Transl Med; 2013 Mar; 2(3):167-74. PubMed ID: 23413376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
    Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell transplantation for amyotrophic lateral sclerosis.
    Baloh RH; Glass JD; Svendsen CN
    Curr Opin Neurol; 2018 Oct; 31(5):655-661. PubMed ID: 30080719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of stem cells therapy in amyotrophic lateral sclerosis.
    Je G; Keyhanian K; Ghasemi M
    Neurol Res; 2021 Aug; 43(8):616-632. PubMed ID: 33632084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.